Authors:
Alvarez, P
Gimeno, J
Lastra, E
Garcia-Granda, S
Van der Maelen, JF
Bassetti, M
Citation: P. Alvarez et al., Synthesis and reactivity of indenyl ruthenium(II) complexes containing thelabile ligand 1,5-cyclooctadiene (COD): Catalytic activity of [Ru(eta(5)-C9H7)Cl(COD)], ORGANOMETAL, 20(17), 2001, pp. 3762-3771
Citation: Tj. Geldbach et al., Synthesis, kinetics, and stereochemistry of P-C bond breaking and P-C bondmaking reactions: Ruthenium-arene binap chemistry, ORGANOMETAL, 20(14), 2001, pp. 2990-2997
Authors:
Bassetti, M
Di Biagio, A
Cenderello, G
Del Bono, V
Palermo, A
Cruciani, M
Bassetti, D
Citation: M. Bassetti et al., Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA), J INFECTION, 43(2), 2001, pp. 148-149
Authors:
Alvarez, P
Bassetti, M
Gimeno, J
Mancini, G
Citation: P. Alvarez et al., Hydration of terminal alkynes to aldehydes in aqueous micellar solutions by ruthenium(II) catalysis; first anti-Markovnikov addition of water to propargylic alcohols, TETRAHEDR L, 42(48), 2001, pp. 8467-8470
Authors:
Bassetti, M
Di Biagio, A
Rebesco, B
Amalfitano, ME
Topal, J
Bassetti, D
Citation: M. Bassetti et al., The effect of formulary restriction in the use of antibiotics in an Italian hospital, EUR J CL PH, 57(6-7), 2001, pp. 529-534
Authors:
Gold, ES
Morrissette, NS
Underhill, DM
Guo, J
Bassetti, M
Aderem, A
Citation: Es. Gold et al., Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis, IMMUNITY, 12(3), 2000, pp. 285-292
Authors:
Del Bono, V
Pretolesi, F
Pontali, E
Martinoli, C
Bassetti, M
Mazzarello, G
Chiaramondia, M
Derchi, LE
Bassetti, D
Citation: V. Del Bono et al., Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: Report of three cases, CLIN INF D, 30(6), 2000, pp. 947-949
Authors:
Bassetti, M
Di Biagio, A
Rebesco, B
Cenderello, G
Amalfitano, ME
Bassetti, D
Citation: M. Bassetti et al., Impact of an antimicrobial formulary and restriction policy in the largesthospital in Italy, INT J ANT A, 16(3), 2000, pp. 295-299
Authors:
Beltrame, A
Del Bono, V
Marturano, M
Pedemonte, P
Rosso, R
Mazzarello, G
Bassetti, M
Collida, A
Fusco, F
Bassetti, D
Citation: A. Beltrame et al., Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow up, INT J ANT A, 16(3), 2000, pp. 361-362
Authors:
Bassetti, M
Collida, A
Rossi, R
Cruciani, M
Di Biagio, A
Bassetti, D
Citation: M. Bassetti et al., Use of antibiotics in an Italian children's hospital, 1993-1995; clinical and economic considerations, INT J ANT A, 14(1), 2000, pp. 33-37
Authors:
Gatti, G
Vigano, A
Sala, N
Vella, S
Bassetti, M
Bassetti, D
Principi, N
Citation: G. Gatti et al., Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection, ANTIM AG CH, 44(3), 2000, pp. 752-755
Authors:
Gatti, G
Di Biagio, A
De Pascalis, CR
Guerra, M
Bassetti, M
Bassetti, D
Citation: G. Gatti et al., Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome, BR J CL PH, 48(5), 1999, pp. 704-711
Authors:
Gatti, G
Di Biagio, A
Casazza, R
De Pascalis, C
Bassetti, M
Cruciani, M
Vella, S
Bassetti, D
Citation: G. Gatti et al., The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring, AIDS, 13(15), 1999, pp. 2083-2089